Lehrstuhl für Haut- und Geschlechtskrankheiten

Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Mohr P, Schober K, Kiecker F, et al. Conference contribution Clinical characteristics and outcomes of coronavirus 2019 disease (COVID-19) in cancer patients treated with immune checkpoint inhibitors (ICI). (2020) Rogiers A, Tondini C, Grimes JM, Trager MH, Nahm S, Zubiri L, Papneja N, et al. Conference contribution HSV-1 Modulates IL-6 Receptor Expression on Human Dendritic Cells (2020) Birzer A, Krawczyk A, Draßner C, Kuhnt C, Mühl-Zürbes P, Heilingloh C, Steinkasserer A, Popella L Journal article Treatment Decision when there is an Indication for adjuvant Therapy for Melanoma - multicenter Real World Data (2020) Lodde G, Forschner A, Wulfken LM, Meier F, Mohr P, Kaehler KC, Schilling B, et al. Conference contribution SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy (2020) Kramer R, Mentzer D, Erdmann M, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel S, et al. Conference contribution Effectiveness of Dabrafenib plus Trametinib during the Treatment of Melanoma Patients with BRAFV600 mutated Brain Metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Schober K, Mohr P, Kiecker F, et al. Conference contribution The Quality of Guidelines for the Treatment of Cutaneous Melanoma: A methodological Assessment (2020) Steeb T, Wessely A, Drexler K, Salzmann M, Toussaint F, Heinzerling L, Reinholz M, et al. Conference contribution Cryopreservation reduces the Ability to migrate and the Cytotoxicity of natural Killer Cells in 3D: Possible Effects on cellular Immunotherapy (2020) Mark C, Czerwinksi T, Roessner S, Mainka A, Hoersch F, Heublein L, Winterl A, et al. Conference contribution The Neural Crest Transcription Factor SOX10 is essential for the Survival of Uveal Melanoma Cells (2020) Wessely A, Kammerbauer C, Berking C, Heppt M Conference contribution Step-by-step Improvement of mRNA-electroporated dendritic Cells in a Phase I / II Clinical Study in cutaneous Melanoma Patients: better Survival correlates with a higher Immunoscore and increased Expression of PEBP1 in the Blood (2020) Dörrie J, Schaft N, Gross S, Ostalecki C, Eberhardt M, Vera-Gonzales J, Uslu U, et al. Conference contribution